Nominate: Xconomy Awards →
May 13, 2020 · Boston
June 8, 2020 · National
September 1, 2020 · San Francisco
Revolutions begin with a bold, unique idea. It’s the scientific observation that spawns a new way of making drugs, the creative business strategy that shakes up the healthcare system, or the policy innovation that speeds new treatments to market. We’ll honor the people, companies, and organizations whose big ideas are making a big impact.
We are all charged with a social conscience and so we are rewarding the individual or company that has looked beyond patients and shareholders to the wider community. Whether this is a one-off philanthropic act or a longer-term outreach scheme, this award will honor those who are focused on giving something back to those less fortunate.
Has a financial partner allowed scientists to discover something otherwise forgotten, or has a last-minute collaboration saved a candidate from the brink of an unfinanced trial collapse to commercial success? This award is all about the money, so we are looking at which funding partnership has shaken the industry and positively affected the biotech space.
We’re looking to honor the region, company, or individual that has shown the most resourcefulness and accomplishment into generating a life sciences environment.
This award looks to honor a specific building, cluster or incubator that goes beyond the normal R&D fixtures and facilitates an unrivalled atmosphere of invention and innovation.
A breakthrough product, an unexpected secondary indication, an unparalleled level of patient success? We are looking beyond a molecule’s commercial success and its topline potential to honor a therapy that has got both the industry and the mainstream tongues wagging.
Patients have become more empowered in drug development and healthcare, advocating for more R&D, fairer drug prices and better access to drugs and their own health data. Patients are also partnering with researchers, companies and other organizations to make sure their voices are heard. This award will recognize people, companies and organizations that are prioritizing the needs of patients, through unique business and drug pricing strategies, creative partnerships, or other initiatives that put patients first.
When two become one something very beautiful can happen, not least in the often isolated and protected world of drug discovery and development. So we are looking to award those who have come together to share assets and ideas that ushered in a great scientific achievement.
We all have a secret weapon on our team: someone whose accomplishments and impact far exceed the credit they’ve received. Whether it’s a member of the C-suite or executive team, a more junior employee, a patient, an advocate, or someone else in your organization or community, we want to give these unsung heroes the recognition they deserve.
Apps, hardware, mobile devices, big data and more—the latest advances in digital technologies are transforming not just drug discovery and medicine, but also how patients collect and use their own health data. This award will go to the person, company, or organization that is pushing the boundaries of how digital tools can ultimately improve health.
Who has been the biggest influence and inspiration within the industry? This award goes to a person who has been instrumental in shaping the biotech landscape. This may be by: drumming up billions of dollars of investment to stimulate R&D; the direct development of numerous life-changing therapeutics; advocacy efforts aiding the space. Whatever the role, this person has turned the industry upside down and made their mark in the national and international biopharma space.
Some folks are so unique they need their own category. We want suggestions not only for which person, company, or organization deserves to win an award, but also for the category they belong in. As long as it fits on a trophy, that is.
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.